Mitral endocarditis due to Rothia aeria with cerebral haemorrhage and femoral mycotic aneurysms, first French description  by Collarino, R. et al.
FIRST CLINICAL CASE REPORTMitral endocarditis due to Rothia aeria with cerebral haemorrhage and
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Bichat-Claude Bernard, APHP, Paris, France and 3) Bacteriology Departments, University Hospital Bichat-Claude Bernard, APHP, Paris, FranceAbstractRothia aeria is a Rothia species from the Micrococcaceae family. We report here the ﬁrst French R. aeria endocarditis complicated by brain
haemorrhage and femoral mycotic aneurysms. Altogether, severity and antimicrobial susceptibility should make us consider the
management of R. aeria endocarditis as Staphylococcus aureus methicillin-susceptible endocarditis.
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E-mail: alexandre.bleibtreu@aphp.frIntroductionRothia species are Gram-positive bacteria belonging to the
Micrococcaceae family [1]. Rothia cause a wide range of serious
infections, especially in immunocompromised hosts [2]. Rothia
aeria colonizes the human oral cavity and upper gastrointestinal
tract [3]. It is an uncommon pathogen associated with infectious
endocarditis (IE). We report the ﬁrst French case of R. aeria IE
complicated by brain haemorrhage and femoral mycotic aneu-
rysms, in an immunocompetent patient.Case reportA 57-year-old man born in Nepal was hospitalized in January
2016 for fever reaching 39.4°C, chills, diarrhoea and headache.
He had lived in the Paris area for the last 30 years. He had a
previous history, in 2008, of right sub-thalamic ischaemicw Microbe and New Infect 2016; 13: 40–42
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p://dx.doi.org/10.1016/j.nmni.2016.06.004stroke and severe mitral insufﬁciency without ventricular
dysfunction for dystrophic mitral valve. He did not have recent
dental care and had no history of intravenous drug injections.
At admission the patient presented with an already known 4/6
meso-systolic rough mitral murmur without cardiac failure and
a painful erythema of the right hand (Fig. 1a). The hand’s ery-
thema disappeared in 2 days. Two aerobically incubated blood
cultures performed at admission were positive with Gram-
positive branching ﬁlamentous bacilli (Fig. 1b,c) within 41 and
86 h, as were the seven other blood culture sets. Colonies
were identiﬁed as R. aeria using matrix-assisted laser
desorption-ionization time-of-ﬂight mass spectrometry (see
Fig. 2). Drug susceptibility showed susceptibility to ampicillin
(MIC 0.016 mg/L). Trans-oesophageal echocardiography
revealed mitral IE with several nearby vegetations of the ring
base, ﬂail P1 without heart dysfunction or abscess (Fig. 1f). Pre-
operative screening for systemic embolism showed a left
frontal subarachnoid haemorrhage on brain magnetic reso-
nance imaging and a hypermetabolic focus in the femoral artery
compatible with a mycotic aneurysm on positron emission
tomodensitometry (Fig. 1d,f). Empiric antibiotherapy was
introduced according to European guidelines [4] with intrave-
nous amoxicillin 2 g every 4 h and gentamicin 3 mg/kg once a
day. Surgical mitral replacement by bio-prosthesis with annular
reconstruction was performed according to the risk of cerebralobiology and Infectious Diseases
nses/by-nc-nd/4.0/)
FIG. 1. Rothia aeria endocarditis, clinical, bacteriological and radiological features. (a) Tenosynovitis of the right hand. (b, c) Gram staining with Gram-
positive bacilli forming branched chains. (d) Brain magnetic resonance imaging in FLAIR sequence with left frontal subarachnoid haemorrhage. (e)
Hypermetabolic focus of the mitral annulus indicated by red arrow at 18ﬂudeoxyglucose positron emission tomography scan. Moderately hyper-
metabolic focus in the middle third of the left deep femoral artery pointed with red arrow at 18ﬂudeoxyglucose positron emission tomography scan. (f)
Trans-oesophageal echocardiography with vegetation indicated by white arrow.
FIG. 2. Matrix-assisted laser desorption/ionization-time of ﬂight mass spectrometry proﬁle for the Rothia aeria isolated in the patient blood culture.
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42 New Microbes and New Infections, Volume 13 Number C, September 2016 NMNIembolism and cardiac abscess at day 10 after initiation of an-
tibiotics. Blood culture negativity was obtained at day 3 after
antibiotics initiation and valvular culture was negative. 16S
rRNA gene sequence analysis was performed on the mitral
sample and conﬁrmed the identiﬁcation of R. aeria (GenBank
Accession sequence KX270977) with a maximal identity of
100% for R. aeria type strain A1-17B (GenBank accession
number AB071952). Antibiotic combination was maintained
for 2 weeks, then amoxicillin alone for a further 4 weeks. All
clinical and biological symptoms resolved. Subarachnoid hae-
morrhage regressed and trans-oesophageal echocardiography
showed a good functioning of the prosthesis and the absence of
added elements.DiscussionInitially R. aeria was known as Rothia dentocariosa genomovar II
[5] and could be mistaken for Nocardia spp. except for its
antibiotic sensitivity [6]. Infective endocardites due to R. aeria
(n = 7) and R. dentocariosa (n = 25), are reported to be associ-
ated with central nervous system involvement in 13 of the 32
cases (40%) published [7–9]. Antibiotic susceptibility of the
R. aeria strains isolated in all case reports showed sensitivity for
ampicillin and gentamicin.
We report the ﬁrst infective IE due to R. aeria described in
France and conﬁrm that R. aeria IE is serious and associated
with mycotic aneurysms and central nervous system involve-
ment. Fast and aggressive management with an antibiotic
combination including penicillin for 4–6 weeks, and valve
replacement when necessary, is required and could limit the
occurrence of complications and death.© 2016 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Micr
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